Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
EUROPE
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest Italy Pharma News, including the government’s decision to make COVID-19 vaccines mandatory for all…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
Switzerland / Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the…
The Long Read / Switzerland: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
Switzerland / Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by…
UK / Top 10 Fastest Growing Private Pharma Companies 2021
The top 10 fastest-growing private pharma companies in the UK for 2021, compiled by corporate finance advisory firm…
Switzerland / The Quest for Alternatives to Animal Testing
Animal testing for medicinal purposes is back under the spotlight in Switzerland after a petition against the…
In Conversation
Hilde Bech – General Manager, BMS Norway
BMS Norway’s Hilde Bech outlines her hopes of bringing “the medicines of the future” to Norwegian patients, why tiny Norway still has global significance for the company, and offers some pearls of wisdom for the next generation of female leaders. BMS Norway is absolutely going to be one of Norway’s largest companies in terms of value How did you…
Latest Reports
Focus on Austria
Sandoz Bolsters its European Essential Medicine…
In the wake of the COVID-19 crisis and the subsequent strain placed on medicine…
Austria: Nucleus of Clinical Trials
Like a family recipe that has been refined and perfected over countless…
Read more from Austria >>
Focus on United Kingdom
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Read more from United Kingdom >>
Focus on Germany
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more…
German Pharma: Highest Honours for BioNTech Founders;…
A roundup of some of the most important recent news from German pharma,…
Read more from Germany >>
Focus on Switzerland
Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Read more from Switzerland >>
Germany / The Biotech Behind Pfizer’s COVID-19 Vaccine Candidate
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
Tattoo Sensor Technology: The Future of Maltese Innovation?
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and…
First Impressions / Swedish Pharma
Though far from the largest pharma market in Europe, Sweden nevertheless holds strategic importance for global…
Brexit / Uncertainty Still Reigns for UK Life Sciences
Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British…
Switzerland / Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the…
The Long Read / Switzerland: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…